Stereotaxis, Inc. STXS
Set alert
At close
Pre-market · Nov 3, 8:07 AM ET
- YTD
- -61.73%
- 1 year
- -68.34%
- Open
- 0.8758
- Prev close
- 0.8626
- Mkt cap
- 88.19M
- Vol
- 532.67K
- Avg vol
- 584.40K
- EPS
- -0.24
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.8702
- High
- 0.9267
- Forward P/E
- -13.06
- Beta
- 1.55
- Short ratio
- 6.26
- Inst. own
- 48.48%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.08
- 200-d avg
- 2.14
- 1y target
- 4.50
1D chart
Signals (22)
| Name | Time | Ago |
|---|---|---|
| MACD: Buy Signal | 12:59 PM | 19 hours ago |
| MACD: Sell Signal | 12:57 PM | 19 hours ago |
| MACD: Buy Signal | 12:39 PM | 19 hours ago |
| RSI: Oversold | 12:23 PM | 19 hours ago |
| SMA: Bearish | 12:20 PM | 19 hours ago |
| SMA: Bearish | 12:10 PM | 20 hours ago |
| RSI: Overbought | 11:56 AM | 20 hours ago |
| MACD: Sell Signal | 11:53 AM | 20 hours ago |
| SMA: Bullish | 11:36 AM | 20 hours ago |
| RSI: Overbought | 11:36 AM | 20 hours ago |
| SMA: Bullish | 11:31 AM | 20 hours ago |
| MACD: Buy Signal | 11:19 AM | 20 hours ago |
| RSI: Oversold | 11:05 AM | 21 hours ago |
| SMA: Bearish | 11:03 AM | 21 hours ago |
| SMA: Bearish | 11:01 AM | 21 hours ago |
| MACD: Sell Signal | 10:48 AM | 21 hours ago |
| RSI: Overbought | 10:43 AM | 21 hours ago |
| RSI: Overbought | 10:40 AM | 21 hours ago |
| MACD: Buy Signal | 10:37 AM | 21 hours ago |
| SMA: Bullish | 10:31 AM | 21 hours ago |
Newest 20 of 22.
Key statistics
- Market cap
- 199.11M
- Enterprise value
- 199.95M
- Trailing P/E
- 0.00
- Forward P/E
- -13.06
- PEG ratio
- 0.00
- Price / sales
- 7.92
- Price / book
- 18.36
- EPS (TTM)
- -0.27
- Beta
- 1.55
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -85.79%
- Revenue (TTM)
- 25.14M
- Revenue growth
- 17.90%
- Free cash flow
- 0
- Total cash
- 10.66M
- Total debt
- 6.13M
- Return on equity
- -106.46%
- Shares outstanding
- 84.73M
- Short % of float
- 3.65%
- 50-day average
- 2.08
- 200-day average
- 2.14
Analyst view
Consensus: strong buy
- Target (low)
- 4.00
- Target (mean)
- 4.50
- Target (high)
- 5.00
- Strong buy2
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.065.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | -0.05 | -0.08 | -0.03 | -60.00% |
| Aug 12, 2024 | Jun 1, 2024 | -0.04 | -0.07 | -0.03 | -75.00% |
| May 13, 2024 | Mar 1, 2024 | -0.07 | -0.06 | +0.01 | +14.29% |
| Mar 4, 2024 | Dec 1, 2023 | -0.07 | -0.07 | 0.00 | 0.00% |
| Nov 9, 2023 | Sep 1, 2023 | -0.05 | -0.07 | -0.02 | -40.00% |
| Aug 10, 2023 | Jun 1, 2023 | -0.06 | -0.07 | -0.01 | -16.67% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 5, 2024 | Lake Street | main | Buy | Buy |
| Mar 5, 2024 | Roth MKM | reit | Buy | Buy |
| Jan 10, 2024 | Roth MKM | init | — | Buy |
| Mar 6, 2023 | Piper Sandler | main | — | Overweight |
| Mar 6, 2023 | Lake Street | main | — | Buy |
| Mar 6, 2023 | B. Riley Securities | main | — | Buy |
About Stereotaxis, Inc.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- stereotaxis.com
News
- Stereotaxis Announces 100% Clinical Success Rate For Its Robocath's Robotic System At Transcatheter Cardiovascular Therapeutics Conference; Technical Success Reported At 95%
- First-in-Human Coronary Intervention Study Results of Robocath's Next-Generation Robotic System Highlighted at TCT
- Canon Medical Systems, Stereotaxis Announce Technology Compatibility And Commercial Collaboration To Pair Alphenix Interventional Imaging Platform With Genesisx Robotic Magnetic Navigation System
- Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology
- Stereotaxis Says Pauls Stradiņš Clinical University Hospital In Latvia, Establishes Robotic Center For Treatment Of Cardiac Arrhythmias In Latvia And Treats Initial Patients With Genesis Robotic Magnetic Navigation System
- Citizens Maintains Market Outperform on Stereotaxis, Lowers Price Target to $3
- TD Cowen Maintains Buy on Stereotaxis, Lowers Price Target to $3
- Stereotaxis Q2 EPS $(0.05) Beats $(0.06) Estimate, Sales $7.670M Miss $8.350M Estimate
- Why Callan JMB Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Thursday's After-Market Session
Your note
Sign in to keep a note on STXS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BENFER DAVID W | Director | Stock Award(Grant) | Jun 30, 2024 | 581,714 |
| CURET MYRIAM J | Director | Stock Award(Grant) | Jun 30, 2024 | 244,945 |
| FISCHEL NATHAN | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jun 30, 2024 | 14,211,100 |
| ISAAC PAUL J | Director | Purchase | Aug 19, 2024 | 0 |
| LEVIN ROSS B. | Director | Stock Award(Grant) | Jun 30, 2024 | 431,032 |
| MENAWAT ARUN SWARUP PH.D. | Director | Stock Award(Grant) | Jun 30, 2024 | 845,344 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| DAFNA Capital Management, LLC | 20.73% | 13,680,554 | 32.15M | Sep 29, 2024 |
| Lagoda Investment Management, L.P. | 5.80% | 3,830,435 | 9.00M | Sep 29, 2024 |
| Blackrock Inc. | 5.80% | 3,825,580 | 8.99M | Sep 29, 2024 |
| Vanguard Group Inc | 4.69% | 3,093,364 | 7.27M | Sep 29, 2024 |
| Arbiter Partners Capital Management LLC | 4.23% | 2,791,068 | 6.56M | Sep 29, 2024 |
| Redmile Group, LLC | 3.19% | 2,108,219 | 4.95M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.50% | 1,652,361 | 3.88M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.98% | 1,310,144 | 3.08M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.43% | 943,652 | 2.22M | Sep 29, 2024 |
| Mutual Fund Ser Tr-AlphaCentric Robotics & Automation Fund | 0.91% | 600,000 | 1.41M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.85% | 560,263 | 1.32M | Aug 30, 2024 |
| iShares Russell 2000 Growth ETF | 0.67% | 444,220 | 1.04M | Oct 30, 2024 |